←Back to Expert Scholars
Translational Medicine / 转化医学BCMA-Targeted Myeloma Therapy
Adam Cohen
MD
🏢University of Pennsylvania🌐USA
Associate Professor of Medicine
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Adam Cohen has been a key investigator in BCMA-directed CAR-T cell therapy development at the University of Pennsylvania. His research has addressed critical challenges in CAR-T cell manufacturing, T-cell fitness, and toxicity management. He continues to advance next-generation cellular therapy platforms for multiple myeloma.
Share:
🧪Research Fields 研究领域
BCMA CAR-T engineering
T-cell manufacturing
Myeloma cellular therapy
CAR-T toxicity management
Translational immunotherapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Adam Cohen 的研究动态
Follow Adam Cohen's research updates
留下邮箱，当我们发布与 Adam Cohen（University of Pennsylvania）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment